Search Results - Schirelman, M.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A tonic nicotinic brake controls spike timing in striatal spiny projection neurons

    A tonic nicotinic brake controls spike timing in striatal spiny projection neurons by Matityahu, Lior, Malgady, Jeffrey M, Schirelman, Meital, Johansson, Yvonne, Wilking, Jennifer A, Silberberg, Gilad, Goldberg, Joshua A, Plotkin, Joshua L

    Published in eLife
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    620 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis therapeutic approach for the N1303 K nonsense mutation

    620 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis therapeutic approach for the N1303 K nonsense mutation by Oren, Y., Barchad-Avizur, O., Galai, E. Ozeri, Schirelman, M., Blinder, T., Ordan, M., Mordechai, T., Stampfer, C., Cymberknoh, M. Cohen, Kerem, E., Kerem, B.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    601: Antisense-oligonucleotide-splicing modulation as a novel CF therapeutic approach for W1282X mutation

    601: Antisense-oligonucleotide-splicing modulation as a novel CF therapeutic approach for W1282X mutation by Kerem, B., Oren, Y., Avizur-Barchad, O., Ozeri-Galai, E., Elgrabli, R., Schirelman, M., Fogel, T., Ordan, M., Laselva, O., Kerem, E., Bear, C.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    619 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis therapeutic approach for the W1282X nonsense mutation

    619 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis therapeutic approach for the W1282X nonsense mutation by Avizur Barchad, O., Oren, Y., Ozeri Galai, E., Elgrabli, R., Schirelman, M., Blinder, T., Stampfer, C., Ordan, M., Laselvab, O., Cohen Cymberknoh, M., Kerem, E., Bear, C., Kerem, B.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    P028 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis (CF) therapeutic approach for the W1282X nonsense mutation

    P028 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis (CF) therapeutic approach for the W1282X nonsense mutation by Barchad, O. Avizur, Oren, Y.S., Galai, E. Ozeri, Elgrabli, R., Schirelman, M.R., Blinder, T., Stampfer, C.D., Ordan, M., Laselvab, O., Cymberknoh, M. Cohen, Kerem, E., Bear, C.E., Kerem, B.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: